Literature DB >> 20103644

Lung metastasis fails in MMTV-PyMT oncomice lacking S100A4 due to a T-cell deficiency in primary tumors.

Birgitte Grum-Schwensen1, Jörg Klingelhöfer, Mariam Grigorian, Kasper Almholt, Boye Schnack Nielsen, Eugene Lukanidin, Noona Ambartsumian.   

Abstract

Interactions between tumor and stroma cells are essential for the progression of cancer from its initial growth at a primary site to its metastasis to distant organs. The metastasis-stimulating protein S100A4 exerts its function as a stroma cell-derived factor. Genetic depletion of S100A4 significantly reduced the metastatic burden in lungs of PyMT-induced mammary tumors. In S100A4(+/+) PyMT mice, massive leukocyte infiltration at the site of the growing tumor at the stage of malignant transition was associated with increased concentration of extracellular S100A4 in the tumor microenvironment. In contrast, in S100A4(-/-) PyMT tumors, a significant suppression of T-cell infiltration was documented at the transition period. In vitro, the S100A4 protein mediated the attraction of T cells. Moreover, S100A4(+/+), but not S100A4(-/-), fibroblasts stimulated the invasion of T lymphocytes into fibroblast monolayers. In vivo, the presence of S100A4(+/+), but not S100A4(-/-), fibroblasts significantly stimulated the attraction of T lymphocytes to the site of the growing tumor. Increased levels of T cells were also observed in the premetastatic lungs of tumor-bearing mice primed to metastasize by S100A4(+/+) fibroblasts. Treatment of T cells with the S100A4 protein stimulated production of cytokines, particularly granulocyte colony-stimulating factor and eotaxin-2. The same cytokines were detected in the fluid of S100A4(+/+) PyMT tumors at the transition period. We suggest that release of S100A4 in the primary tumor stimulates infiltration of T cells and activates secretion of cytokines, thus triggering sequential events that fuel tumor cells to metastasize. Similar processes could occur in the premetastatic lungs, facilitating generation of inflammatory milieu favorable for metastasis formation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20103644     DOI: 10.1158/0008-5472.CAN-09-3220

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  39 in total

1.  Intradomain cleavage of inhibitory prodomain is essential to protumorigenic function of membrane type-1 matrix metalloproteinase (MT1-MMP) in vivo.

Authors:  Vladislav S Golubkov; Andrei V Chernov; Alex Y Strongin
Journal:  J Biol Chem       Date:  2011-08-08       Impact factor: 5.157

2.  S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma.

Authors:  Kin-Hoe Chow; Hee Jung Park; Joshy George; Keiko Yamamoto; Andrew D Gallup; Joel H Graber; Yuanxin Chen; Wen Jiang; Dennis A Steindler; Eric G Neilson; Betty Y S Kim; Kyuson Yun
Journal:  Cancer Res       Date:  2017-08-14       Impact factor: 12.701

3.  Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis.

Authors:  Leah M Cook; Xuemei Cao; Alexander E Dowell; Michael T Debies; Mick D Edmonds; Benjamin H Beck; Robert A Kesterson; Renee A Desmond; Andra R Frost; Douglas R Hurst; Danny R Welch
Journal:  Clin Exp Metastasis       Date:  2012-01-13       Impact factor: 5.150

4.  VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization.

Authors:  Joyce T O'Connell; Hikaru Sugimoto; Vesselina G Cooke; Brian A MacDonald; Ankit I Mehta; Valerie S LeBleu; Rajan Dewar; Rafael M Rocha; Ricardo R Brentani; Murray B Resnick; Eric G Neilson; Michael Zeisberg; Raghu Kalluri
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-12       Impact factor: 11.205

Review 5.  Leukocytes as paracrine regulators of metastasis and determinants of organ-specific colonization.

Authors:  Neta Erez; Lisa M Coussens
Journal:  Int J Cancer       Date:  2011-03-25       Impact factor: 7.396

6.  Metastasis-inducing S100A4 and RANTES cooperate in promoting tumor progression in mice.

Authors:  Birgitte Forst; Matilde Thye Hansen; Jörg Klingelhöfer; Henrik Devitt Møller; Gitte Helle Nielsen; Birgitte Grum-Schwensen; Noona Ambartsumian; Eugene Lukanidin; Mariam Grigorian
Journal:  PLoS One       Date:  2010-04-28       Impact factor: 3.240

7.  S100A4 in esophageal cancer: is this the one to blame?

Authors:  Jianyuan Chai; M Mazen Jamal
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

Review 8.  Functions of S100 proteins.

Authors:  R Donato; B R Cannon; G Sorci; F Riuzzi; K Hsu; D J Weber; C L Geczy
Journal:  Curr Mol Med       Date:  2013-01       Impact factor: 2.222

Review 9.  Fibroblasts as architects of cancer pathogenesis.

Authors:  Timothy Marsh; Kristian Pietras; Sandra S McAllister
Journal:  Biochim Biophys Acta       Date:  2012-10-30

10.  Efficacy of aerosolized celecoxib encapsulated nanostructured lipid carrier in non-small cell lung cancer in combination with docetaxel.

Authors:  Apurva R Patel; Mahavir B Chougule; Townley I; Ram Patlolla; Guangdi Wang; Mandip Singh
Journal:  Pharm Res       Date:  2013-01-30       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.